Suppressing HMGB1 expression down-regulated the molecular level and activity of Bcl-2, blocked the binding of Bcl-2 to autophagy gene Beclin1, and inhibited autophagy, thus promoted the apoptosis of tumor cells [39]. The gene discussed is BCL2; the disease is neoplasm.